Home » Topics » Regulatory » EMA

EMA
RSS

Theratechnologies gives update on tesamorelin regulatory progress

June 25, 2012

European CHMP adopts opinion on teduglutide

June 25, 2012

Alexza provides update on Adasuve submissions

June 25, 2012

EMA validates MAAs for fixed-dose combination diabetes therapies

June 20, 2012

Investigational gene therapy gets orphan drug status for adrenoleukodystrophy

June 20, 2012

EMA to conduct centralized review of elvitegravir MAA

June 19, 2012

Genta reaches agreement on phase III tesetaxel trial

June 19, 2012

EMA's COMP issues opinion on Enhoxy

June 14, 2012

AR-42 gets E.U. orphan drug status for two additional indications

June 8, 2012

CHMP schedules hearing for Vivus' Qnexa MAA

June 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...